1 Min Read
Jan 12 (Reuters) - EyeGene Inc :
* Says it received U.S. patent on Jan. 12, for vaccines for cervical cancer
* Says patent number is 13/379,212
Source text in Korean: goo.gl/2SJe8v
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.